 |
인쇄하기
취소
|
Nonlisted firms’ net profit 38% up in 2010
Korea’s nonlisted pharmaceutical companies saw their earnings surge 38 percent on-year in 2010 thanks to growing demand, a report showed recently.
The combined sales of 54 firms unlisted on the main bourse posted a 10 percent rise last year, with their operating incomes up 17 percent, according to the report compiled by Yakup Shinmoon (www.yakup.com).
According to the report, these nonlis...
The combined sales of 54 firms unlisted on the main bourse posted a 10 percent rise last year, with their operating incomes up 17 percent, according to the report compiled by Yakup Shinmoon (www.yakup.com).
According to the report, these nonlis...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.